Table 5. Therapeutic action following ctDNA result.

Therapeutic action taken following assay result	Patients, n=34, (%)
FDA approved therapy	2 [6]
Clinical trial	5 [12]
Off label	2 [6]
Treated with non-targeted therapy	9 [26]
Immunotherapy	7 [21]
Other (palliative care, death, result intended for future use, lost to follow-up)	9 [26]

FDA, Federal Drug Administration; ctDNA, circulating tumor DNA.